TY - JOUR AU - Peacock, A. AU - Leung, J. AU - Larney, S. AU - Colledge, S. AU - Hickman, M. AU - Rehm, J. PY - 2018 DA - 2018// TI - Global statistics on alcohol, tobacco and illicit drug use: 2017 status report JO - Addiction VL - 113 UR - https://doi.org/10.1111/add.14234 DO - 10.1111/add.14234 ID - Peacock2018 ER - TY - JOUR AU - Degenhardt, L. AU - Charlson, F. AU - Mathers, B. AU - Hall, W. D. AU - Flaxman, A. D. AU - Johns, N. PY - 2014 DA - 2014// TI - The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study JO - Addiction VL - 109 UR - https://doi.org/10.1111/add.12551 DO - 10.1111/add.12551 ID - Degenhardt2014 ER - TY - JOUR AU - Kim, H. K. AU - Nelson, L. S. PY - 2015 DA - 2015// TI - Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review JO - Expert Opin Drug Saf VL - 14 UR - https://doi.org/10.1517/14740338.2015.1037274 DO - 10.1517/14740338.2015.1037274 ID - Kim2015 ER - TY - JOUR AU - Sivilotti, M. L. PY - 2016 DA - 2016// TI - Flumazenil, naloxone and the ‘coma cocktail’ JO - Br J Clin Pharmacol VL - 81 UR - https://doi.org/10.1111/bcp.12731 DO - 10.1111/bcp.12731 ID - Sivilotti2016 ER - TY - JOUR AU - Khosravi, N. AU - Zamani, N. AU - Hassanian-Moghaddam, H. AU - Ostadi, A. AU - Rahimi, M. AU - Kabir, A. PY - 2017 DA - 2017// TI - Comparison of two naloxone regimens in opioid-dependent methadone overdosed patients: a clinical trial study JO - Curr Clin Pharmacol VL - 12 UR - https://doi.org/10.2174/1574884713666171212112540 DO - 10.2174/1574884713666171212112540 ID - Khosravi2017 ER - TY - JOUR AU - Welsh, C. AU - Sherman, S. G. AU - Tobin, K. E. PY - 2008 DA - 2008// TI - A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone) JO - Addiction VL - 103 UR - https://doi.org/10.1111/j.1360-0443.2008.02244.x DO - 10.1111/j.1360-0443.2008.02244.x ID - Welsh2008 ER - TY - JOUR AU - Yokell, M. A. AU - Zaller, N. D. AU - Green, T. C. AU - McKenzie, M. AU - Rich, J. D. PY - 2012 DA - 2012// TI - Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose JO - J Opioid Manag VL - 8 UR - https://doi.org/10.5055/jom.2012.0098 DO - 10.5055/jom.2012.0098 ID - Yokell2012 ER - TY - JOUR AU - Zamani, N. AU - Hassanian-Moghaddam, H. PY - 2017 DA - 2017// TI - Intravenous buprenorphine: a substitute for naloxone in methadone-overdosed patients? JO - Ann Emerg Med VL - 69 UR - https://doi.org/10.1016/j.annemergmed.2016.12.024 DO - 10.1016/j.annemergmed.2016.12.024 ID - Zamani2017 ER - TY - JOUR AU - Zamani, N. AU - Hassanian-Moghaddam, H. AU - Bayat, A. H. AU - Haghparast, A. AU - Shadnia, S. AU - Rahimi, M. PY - 2015 DA - 2015// TI - Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine JO - Toxicol Lett VL - 232 UR - https://doi.org/10.1016/j.toxlet.2014.12.007 DO - 10.1016/j.toxlet.2014.12.007 ID - Zamani2015 ER - TY - JOUR AU - Hassanian-Moghaddam, H. AU - Zamani, N. AU - Rahimi, M. AU - Shadnia, S. AU - Pajoumand, A. AU - Sarjami, S. PY - 2014 DA - 2014// TI - Acute adult and adolescent poisoning in Tehran, Iran; the epidemiologic trend between 2006 and 2011 JO - Arch Iran Med VL - 17 ID - Hassanian-Moghaddam2014 ER - TY - CHAP AU - Nelson, L. S. AU - Howland, M. A. ED - Hoffman, R. S. ED - Howland, M. A. ED - Lewin, N. A. ED - Nelson, L. S. ED - Goldfrank, L. R. PY - 2015 DA - 2015// TI - Opioid antagonists BT - Goldfrank’s toxicologic emergencies PB - McGraw-Hill CY - New York ID - Nelson2015 ER - TY - JOUR AU - Strain, E. C. AU - Preston, K. L. AU - Liebson, I. A. AU - Bigelow, G. E. PY - 1995 DA - 1995// TI - Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone JO - J Pharmacol Exp Ther VL - 272 ID - Strain1995 ER - TY - JOUR AU - Huestis, M. A. AU - Cone, E. J. AU - Pirnay, S. O. AU - Umbricht, A. AU - Preston, K. L. PY - 2013 DA - 2013// TI - Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans JO - Drug Alcohol Depend VL - 131 UR - https://doi.org/10.1016/j.drugalcdep.2012.11.014 DO - 10.1016/j.drugalcdep.2012.11.014 ID - Huestis2013 ER - TY - JOUR AU - Kuhlman, J. J. AU - Lalani, S. AU - Magluilo, J. AU - Levine, B. AU - Darwin, W. D. PY - 1996 DA - 1996// TI - Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine JO - J Anal Toxicol VL - 20 UR - https://doi.org/10.1093/jat/20.6.369 DO - 10.1093/jat/20.6.369 ID - Kuhlman1996 ER - TY - JOUR AU - Wesson, D. R. AU - Ling, W. PY - 2003 DA - 2003// TI - The Clinical Opiate Withdrawal Scale (COWS) JO - J Psychoactive Drugs VL - 35 UR - https://doi.org/10.1080/02791072.2003.10400007 DO - 10.1080/02791072.2003.10400007 ID - Wesson2003 ER - TY - JOUR AU - Fan, E. AU - Brodie, D. AU - Slutsky, A. S. PY - 2018 DA - 2018// TI - Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment JO - JAMA VL - 319 UR - https://doi.org/10.1001/jama.2017.21907 DO - 10.1001/jama.2017.21907 ID - Fan2018 ER - TY - JOUR AU - Whitehead, A. L. AU - Julious, S. A. AU - Cooper, C. L. AU - Campbell, M. J. PY - 2016 DA - 2016// TI - Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable JO - Stat Methods Med Res VL - 25 UR - https://doi.org/10.1177/0962280215588241 DO - 10.1177/0962280215588241 ID - Whitehead2016 ER - TY - JOUR AU - Strain, E. C. AU - Preston, K. L. AU - Liebson, I. A. AU - Bigelow, G. E. PY - 1992 DA - 1992// TI - Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers JO - J Pharmacol Exp Ther VL - 261 ID - Strain1992 ER - TY - JOUR AU - Kalluri, H. V. AU - Zhang, H. AU - Caritis, S. N. AU - Venkataramanan, R. PY - 2017 DA - 2017// TI - A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration JO - Br J Clin Pharmacol VL - 83 UR - https://doi.org/10.1111/bcp.13368 DO - 10.1111/bcp.13368 ID - Kalluri2017 ER -